Over the past 12 months, 5 insiders at Vaxcyte, Inc. filed 20 open-market SEC Form 4 transactions on PCVX: 0 purchases worth $0 and 20 sales worth $4.1M. Insiders have been net sellers over this period. The most recent filing was on Jul 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 26 | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | SELL | 11.8K | $55.96 | $654K |
| Jul 6, 26 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 7.9K | $57.76 | $452K |
| Jul 1, 26 | Jim WassilCHIEF OPERATING OFFICER | SELL | 1.8K | $57.47 | $100K |
| Jun 18, 26 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 10.0K | $53.00 | $530K |
| Apr 7, 26 | Elvia CowanSVP, Finance & CAO | SELL | 3.0K | $60.00 | $180K |
| Mar 17, 26 | Elvia CowanSVP, Finance & CAO | SELL | 1.5K | $56.26 | $82K |
| Mar 11, 26 | Elvia CowanSVP, Finance & CAO | SELL | 2.5K | $58.59 | $146K |
| Mar 10, 26 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.0K | $59.16 | $294K |
| Dec 31, 25 | Harpreet S. DhaliwalChief Technical Ops Officer | SELL | 9.7K | $46.69 | $455K |
| Dec 23, 25 | Elvia CowanSVP, FINANCE | SELL | 6.7K | $47.94 | $322K |
| Mar 5, 25 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 2.6K | $72.37 | $184K |
| Mar 3, 25 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.9K | $73.84 | $432K |
| Feb 18, 25 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 6.2K | $84.58 | $517K |
| Feb 5, 25 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 1.8K | $91.71 | $162K |
| Feb 3, 25 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.3K | $87.94 | $457K |
| Jan 21, 25 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 5.3K | $87.70 | $458K |
| Jan 15, 25 | Teri LoxamDirector | SELL | 1.2K | $88.54 | $101K |
| Jan 6, 25 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 3.9K | $86.52 | $336K |
| Jan 2, 25 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.5K | $84.43 | $459K |
| Dec 18, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 3.4K | $90.24 | $299K |
| Dec 9, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 1.0K | $93.60 | $95K |
| Dec 5, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 3.2K | $92.90 | $292K |
| Dec 2, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 11.3K | $94.06 | $1.0M |
| Dec 2, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.8K | $94.06 | $531K |
| Nov 18, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 6.1K | $87.05 | $523K |
| Nov 7, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 463 | $105.50 | $48K |
| Nov 5, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 1.5K | $107.50 | $163K |
| Nov 1, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 10.0K | $108.50 | $1.1M |
| Nov 1, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 5.0K | $108.93 | $527K |
| Oct 18, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 36.1K | $116.19 | $4.2M |
| Oct 7, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 3.1K | $111.68 | $345K |
| Oct 7, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 2.1K | $110.35 | $232K |
| Oct 1, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 3.1K | $115.01 | $350K |
| Oct 1, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 9.6K | $114.99 | $1.1M |
| Oct 1, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 3.3K | $114.95 | $383K |
| Sep 18, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 5.5K | $117.53 | $634K |
| Sep 17, 24 | Teri LoxamDirector | SELL | 4.3K | $117.51 | $502K |
| Sep 16, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 8.0K | $116.96 | $928K |
| Sep 3, 24 | Elvia CowanSVP, FINANCE | SELL | 5.0K | $107.67 | $538K |
| Sep 3, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 715 | $117.28 | $80K |
| Sep 3, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 3.1K | $117.03 | $344K |
| Aug 23, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 8.3K | $79.25 | $659K |
| Aug 19, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 5.0K | $79.14 | $391K |
| Aug 1, 24 | Mikhail EydelmanSVP, GEN COUNSEL & CORP SEC | SELL | 1.5K | $79.29 | $117K |
| Aug 1, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 1.3K | $78.80 | $103K |
| Aug 1, 24 | Jim WassilCHIEF OPERATING OFFICER | SELL | 3.0K | $79.47 | $235K |
| Jul 23, 24 | Grant PickeringCHIEF EXECUTIVE OFFICER | SELL | 9.3K | $84.53 | $785K |
| Jul 18, 24 | Andrew GuggenhimePRESIDENT AND CFO | SELL | 3.1K | $83.14 | $248K |
| Jul 16, 24 | Elvia CowanSVP, FINANCE | SELL | 5.0K | $85.00 | $425K |
| Jul 8, 24 | Elvia CowanSVP, FINANCE | SELL | 5.0K | $80.00 | $400K |
Over the past 12 months, insiders at Vaxcyte, Inc. filed 0 open-market purchases worth $0 and 20 sales worth $4.1M on PCVX, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 27, 26.
5 different insiders at Vaxcyte, Inc. filed open-market SEC Form 4 transactions on PCVX over the last 12 months.
InsiderTape plots every PCVX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Vaxcyte, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →